Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Healtheon Paying $5 Bil. For CareInsite, Symbolic Role As New Medco

  • News

Executive Summary

Healtheon/WebMD's acquisition of Medical Manager/CareInsite will allow Healtheon to inherit the image of the next Medco in the physician connectivity field.

You may also be interested in...



Medco Founder Wygod Will Focus On Payor Relations At WebMD As Co-Ceo

Medical Manager Chairman Martin Wygod will focus on the payor side of WebMD's business in his new role as co-CEO following a merger with Healtheon/WebMD.

Medco Founder Wygod Will Focus On Payor Relations At WebMD As Co-Ceo

Medical Manager Chairman Martin Wygod will focus on the payor side of WebMD's business in his new role as co-CEO following a merger with Healtheon/WebMD.

Merck suit against former Medco CEO dismissed

Merck's February 1999 complaint alleging violations of a non-compete agreement by former Medco Chairman Martin Wygod and his new company, Medical Manager/CareInsite, dismissed by New Jersey state court. Wygod will become co-chairman of Healtheon/WebMD following a merger between Healtheon and Medical Manager (1"The Pink Sheet" Feb. 21, p. 13)

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

New EU Filings

See All
UsernamePublicRestriction

Register

PS035631

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By